Corbus Pharmaceuticals Holdings, Inc. — All Filings
757 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
4/A
424B3
424B5
5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-3MEF
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | SC 13G | 0001140361-24-008023 | Feb 14, 2024 | — |
| SC 13G | SC 13G | 0001104659-24-014646 | Feb 12, 2024 | — |
| SC 13G | CORBUS PHARMACEUTICALS HOLDINGS, INC. | 0000902664-24-001435 | Feb 12, 2024 | — |
| SC 13G | — | 0001319244-24-000026 | Feb 9, 2024 | — |
| 4 | — | 0000929638-24-000383 | Feb 6, 2024 | Feb 2, 2024 |
| 8-K | 8-K | 0000950170-24-011733 | Feb 6, 2024 | Feb 2, 2024 |
| 8-K | 8-K | 0000950170-24-011013 | Feb 5, 2024 | — |
| SC 13G | SC 13G | 0001104659-24-010623 | Feb 5, 2024 | — |
| SC 13G | — | 0000929638-24-000374 | Feb 5, 2024 | — |
| 8-K/A | 8-K/A | 0000950170-24-009973 | Feb 2, 2024 | Jan 30, 2024 |
| 8-K | 8-K | 0000950170-24-009874 | Feb 1, 2024 | Jan 30, 2024 |
| 424B5 | 424B5 | 0000950170-24-009865 | Feb 1, 2024 | — |
| 424B5 | 424B5 | 0000950170-24-009084 | Jan 31, 2024 | — |
| 8-K | 8-K | 0000950170-24-009086 | Jan 31, 2024 | Jan 30, 2024 |
| S-3MEF | S-3MEF | 0000950170-24-009164 | Jan 31, 2024 | — |
| 4 | — | 0000929638-24-000304 | Jan 30, 2024 | Jan 26, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-002419 | Jan 30, 2024 | Jan 26, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-002449 | Jan 30, 2024 | Jan 26, 2024 |
| 3 | — | 0000929638-24-000303 | Jan 30, 2024 | Jan 26, 2024 |
| 8-K | 8-K | 0000950170-24-008129 | Jan 29, 2024 | — |
| SC 13G | CORBUS PHARMACEUTICALS HOLDINGS, INC. | 0000902664-24-000754 | Jan 29, 2024 | — |
| 424B3 | 424B3 | 0000950170-24-008127 | Jan 29, 2024 | — |
| 8-K | 8-K | 0000950170-24-007703 | Jan 26, 2024 | — |
| SC 13G | — | 0001214659-24-001240 | Jan 26, 2024 | — |
| 8-K | 8-K | 0000950170-24-003197 | Jan 9, 2024 | Jan 8, 2024 |
| 8-K | 8-K | 0000950170-23-063854 | Nov 14, 2023 | — |
| 8-K | 8-K | 0000950170-23-063134 | Nov 13, 2023 | Nov 10, 2023 |
| 10-Q | 10-Q | 0000950170-23-060377 | Nov 7, 2023 | Sep 30, 2023 |
| 8-K | 8-K | 0000950170-23-059812 | Nov 7, 2023 | — |
| 8-K | 8-K | 0000950170-23-039409 | Aug 8, 2023 | — |
| 10-Q | 10-Q | 0000950170-23-039960 | Aug 8, 2023 | Jun 30, 2023 |
| 8-K | 8-K | 0000950170-23-037620 | Aug 3, 2023 | — |
| 424B3 | 424B3 | 0000950170-23-027746 | Jun 13, 2023 | — |
| EFFECT | — | 9999999995-23-001739 | Jun 13, 2023 | — |
| S-3/A | S-3/A | 0001193125-23-165391 | Jun 12, 2023 | — |
| CORRESP | — | 0000950170-23-026822 | Jun 7, 2023 | — |
| UPLOAD | — | 0000000000-23-006053 | Jun 7, 2023 | — |
| S-3 | S-3 | 0001193125-23-158143 | Jun 1, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-23-031474 | May 22, 2023 | May 18, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-031441 | May 22, 2023 | May 18, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-031448 | May 22, 2023 | May 18, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-031453 | May 22, 2023 | May 18, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-031460 | May 22, 2023 | May 18, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-031467 | May 22, 2023 | May 18, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-031471 | May 22, 2023 | May 18, 2023 |
| 8-K | 8-K | 0000950170-23-023162 | May 19, 2023 | May 18, 2023 |
| 8-K | 8-K | 0000950170-23-019170 | May 9, 2023 | — |
| 10-Q | 10-Q | 0000950170-23-019825 | May 9, 2023 | Mar 31, 2023 |
| 8-K/A | 8-K/A | 0000950170-23-014119 | Apr 24, 2023 | Mar 3, 2023 |
| DEFA14A | DEFA14A | 0000950170-23-011610 | Apr 3, 2023 | — |